Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Roten, L; Sacher, F; Daly, M; Pascale, P; Komatsu, Y; Ramoul, K; Scherr, D; Chaumeil, A; Shah, A; Denis, A; Derval, N; Hocini, M; Haïssaguerre, M; Jaïs, P.
Epicardial Ventricular Tachycardia Ablation for Which Patients?
Arrhythm Electrophysiol Rev. 2012; 1(1): 39-45.
Doi: 10.15420/aer.2012.1.1.39
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Scherr Daniel
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- With the widespread use of implantable cardioverter-defibrillators, an increasing number of patients present with ventricular tachycardia (VT). Large multicentre studies have shown that ablation of VT successfully reduces recurrent VT and this procedure is being performed by an increasing number of centres. However, for a number of reasons, many patients experience VT recurrence after ablation. One important reason for VT recurrence is the presence of an epicardial substrate involved in the VT circuit which is not affected by endocardial ablation. Epicardial access and ablation is now frequently performed either after failed endocardial VT ablation or as first-line treatment in selected patients. This review will focus on the available evidence for identifying VT of epicardial origin, and discuss in which patients an epicardial approach would be benefitial.